Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas-Reference-Cited by-同舟云学术

Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas

Published:2021-02-04 Issue:11 Volume:27 Page:3126-3140
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Corso Simona^ORCID,Pietrantonio Filippo^ORCID,Apicella Maria,Migliore Cristina^ORCID,Conticelli Daniela^ORCID,Petrelli Annalisa,D'Errico Laura,Durando Stefania^ORCID,Moya-Rull Daniel,Bellomo Sara E.^ORCID,Ughetto Stefano,Degiuli Maurizio^ORCID,Reddavid Rossella^ORCID,Fumagalli Uberto,De Pascale Stefano,Sgroi Giovanni^ORCID,Rausa Emanuele^ORCID,Baiocchi Gian Luca^ORCID,Molfino Sarah,De Manzoni Giovanni,Bencivenga Maria,Siena Salvatore^ORCID,Sartore-Bianchi Andrea^ORCID,Morano Federica^ORCID,Corallo Salvatore^ORCID,Prisciandaro Michele^ORCID,Di Bartolomeo Maria,Gloghini Annunziata^ORCID,Marsoni Silvia^ORCID,Sottile Antonino,Sapino Anna^ORCID,Marchiò Caterina^ORCID,Dahle-Smith Asa,Miedzybrodzka Zosia^ORCID,Lee Jessica,Ali Siraj M.^ORCID,Ross Jeffrey S.^ORCID,Alexander Brian M.^ORCID,Miller Vincent A.,Petty Russell,Schrock Alexa B.,Giordano Silvia^ORCID

Funder

Italian Association for Cancer Research

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin for gastric cancer: Mechanism prediction via network pharmacology, docking, and in vitro experiments;World Journal of Gastrointestinal Oncology;2024-08-15

2. Identification of the Mechanism of Action of the Index Components of Banxia Xiexin Decoction for Gastric Cancer through Network Pharmacology, Bioinformatics, and Molecular Docking Analysis;Journal of Chemistry;2024-01-13

3. Tubulin degradation: Principles, agents, and applications;Bioorganic Chemistry;2023-10

4. Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer;Cancer Discovery;2023-06-28

5. Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer;Pharmaceutics;2022-08-23